GGrantIndex
← Leaderboards

Kristina Anne Crothers

Va Puget Sound Healthcare System

$11,792,590
Attributed
$22,874,626
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,874,626 · 11
VA$0 · 1

By mechanism

R01$15,985,462 · 6
U01$2,773,611 · 1
T32$1,634,279 · 1
R56$1,482,982 · 2
RC1$998,292 · 1
I01$0 · 1

Most similar at Va Puget Sound Healthcare System

Same institution · by research overlap

Others in their field

Top investigators on “Caring

Research focus

CaringLungAgingVeteransCohort StudiesProgramsInfectionSmokingRisk FactorsComorbidityMorbidity - Disease RateResearch PersonnelMortalityHiv InfectionsMultidisciplinaryLung DiseasesSeveritiesChronic Obstructive Airway DiseaseBaseSmokerAntiretroviral TherapyChronicIncidencePersons

Grant awards (44)

Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV)$803,801
R01 · FY2025 · HL · contact PI
Pulmonary and Critical Care Medicine Research Training Grant$777,377
T32 · FY2025 · HL · contact PI
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients$667,628
R01 · FY2025 · HL
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV$305,838
R01 · FY2025 · CA · contact PI
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)$0
I01 · FY2025 · VA · contact PI
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients$675,830
R01 · FY2024 · HL
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)$0
I01 · FY2024 · VA · contact PI
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients$685,518
R01 · FY2023 · HL
Pulmonary and Critical Care Medicine Training Grant$335,668
T32 · FY2023 · HL
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV$250,000
R01 · FY2023 · CA · contact PI
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)$0
I01 · FY2023 · VA · contact PI
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients$739,732
R01 · FY2022 · HL
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV$576,488
R01 · FY2022 · CA · contact PI
Pulmonary and Critical Care Medicine Training Grant$521,234
T32 · FY2022 · HL
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)$0
I01 · FY2022 · VA · contact PI
AdvanCing High quality COPD care for people with immune dysfunction by implementing Evidence-based management through proactive E-consults (ACHIEVE)$658,660
U01 · FY2021 · HL
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV$595,015
R01 · FY2021 · CA · contact PI
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)$0
I01 · FY2021 · VA · contact PI
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV$695,630
R01 · FY2020 · CA · contact PI
AdvanCing High quality COPD care for people with immune dysfunction by implementing Evidence-based management through proactive E-consults (ACHIEVE)$681,154
U01 · FY2020 · HL
AdvanCing High quality COPD care for people with immune dysfunction by implementing Evidence-based management through proactive E-consults (ACHIEVE)$693,541
U01 · FY2019 · HL
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV$638,150
R01 · FY2019 · CA · contact PI
AdvanCing High quality COPD care for people with immune dysfunction by implementing Evidence-based management through proactive E-consults (ACHIEVE)$740,256
U01 · FY2018 · HL
HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$730,982
R01 · FY2018 · HL · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$416,472
R01 · FY2017 · CA · contact PI
HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$698,438
R01 · FY2016 · HL · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$420,665
R01 · FY2016 · CA · contact PI
HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$678,741
R01 · FY2015 · HL · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$446,246
R01 · FY2015 · CA · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$178,343
R01 · FY2015 · CA · contact PI
Cardiovascular, Pulmonary and Hematological Disease in HIV: Prevention and Treatment$799,368
R56 · FY2014 · HL
HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$690,967
R01 · FY2014 · HL · contact PI
Endothelial mechanisms of impaired lung gas exchange by HIV$572,938
R56 · FY2014 · HL
Benefits and Harms of Lung Cancer Screening in HIV Infection$483,682
R01 · FY2014 · CA · contact PI
Endothelial mechanisms of impaired lung gas exchange by HIV$110,676
R56 · FY2014 · HL
Benefits and Harms of Lung Cancer Screening in HIV Infection$573,861
R01 · FY2013 · CA · contact PI
Longitudinal Studies of HIV-Associated Lung Infections and Complications$691,883
R01 · FY2011 · HL · contact PI
Longitudinal Studies of HIV-Associated Lung Infections and Complications$690,775
R01 · FY2010 · HL · contact PI
Risk, Severity and Outcome of Bacterial Pneumonia in an HIV +/- Veteran Cohort$498,302
RC1 · FY2010 · HL · contact PI
Longitudinal Studies of HIV-Associated Lung Infections and Complications$759,809
R01 · FY2009 · HL · contact PI
Risk, Severity and Outcome of Bacterial Pneumonia in an HIV +/- Veteran Cohort$499,990
RC1 · FY2009 · HL · contact PI
Longitudinal Studies of HIV-Associated Lung Infections and Complications$314,594
R01 · FY2009 · HL · contact PI
Longitudinal Studies of HIV-Associated Lung Infections and Complications$762,936
R01 · FY2008 · HL · contact PI
Longitudinal Studies of HIV-Associated Lung Infections and Complications$813,438
R01 · FY2007 · HL · contact PI